Dasan®

Dasatinib

Therapeutic action

Antineoplastic. Tyrosine kinase inhibitor

Indications

Philadelphia chromosome-positive acute lymphoblastic leukemia / Chronic myeloid leukemia

Presentation

Coated tablets of 20 mg, 50 mg, 70 mg and 100 mg